17:25 EST ADC Therapeutics (ADCT) files to sell 14.7M common shares for holders
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ADCT:
- ADC Therapeutics reports Q3 adjsuted EPS (19c), consensus (36c)
- Is ADCT a Buy, Before Earnings?
- ADC Therapeutics’ LOTIS-7 Study: A Promising Update for Investors
- ADC Therapeutics’ LOTIS-10 Study: A Step Forward in Lymphoma Treatment
- ADC Therapeutics price target lowered to $7 from $8 at H.C. Wainwright